Catalyst

Slingshot members are tracking this event:

BioPharmX Announces Final Phase 2a Trial Results Find BPX-01 Reduces Facial P. Acnes by More than 90% in Four Weeks

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
BPMX

100%

Additional Information

Additional Relevant Details
- BPX-01 significantly outperformed control vehicle- BPX-01 showed no detectable minocycline in bloodstream- Daily 10 mg dose of topical minocycline offered P. acnes reduction comparable to oral minocycline at 20 times the daily dose
http://biopharmx.inv...
Slingshot Insights Explained
Catalyst Date
Occurred on:
Aug 22, 2016
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Minocycline, Bpx-01, Acne